Media Watch
Tag:
The ‘what’ is no good without the ‘why’
Instead of simply regurgitating stats and facts without contextualising or explaining them, a health-e article published in The Star (26 April 2012) explains the reasons why there are more women in ART programmes than men.
The subject of the article is a study that found that ART uptake increased from 47, 500 to 1.79 million between 2004 and 2011. One-third of all HIV-positive South Africans are currently accessing HIV treatment.
Of particular interest, however, are the differences in ART uptake between men and women.
IN THE NEWS: Aids hits Muslim community
The most frequently cited study of HIV in the Muslim community found that more than 2.5% of Muslim men were HIV-positive. That is significantly lower than South Africa's general population but enough to worry leaders in the community. Health-e News Service visited a centre that's reaching out to support women and children affected by HIV.IN THE NEWS: KZN rolls out dodgy circumcision Klamp despite questions
HIV activists and senior doctors have called for an urgent investigation into the continued rollout of a controversial male circumcision device in KwaZulu-Natal.Positive role model predicament
A health-e article syndicated in an edition of The New Age this week examined the ins and outs of singling out people living with HIV as role models.HIV and obesity a weighty issue
According to articles published by Health-e and Drum Magazine a new trend of intentionally gaining weight is emerging amongst those living with HIV.
Doctors indicate that people engaging in this behaviour are trying to distance themselves from thinness, which is often associated with HIV and AIDS.
But people living with the virus need to be warned against the consumption of fatty foods because they can interfere with the absorption of ARVs.
SA HIV prevention to get shot in the arm
Hopes of eradicating HIV run high as the latest and greatest HIV vaccine trial heads to SA.
The Star and online news provider health-e report that the RV144 vaccine met with unprecedented success in trials conducted in Thailand.
Page 1 of 1 pages
